Theriva Biologics Announces First Patient Dosed in VIRAGE, a Phase 2b Trial of Systemically…
-Initiation of Phase 2b trial follows clearance from the US Food and Drug Administration (FDA) and Spanish Agency for Medicines and Health Products (AEMPS)- -The first patient was dosed in Spain; trial expected to enroll 92 adults at…